Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pituitary Neoplasms 7Prolactinoma 6Polycystic Ovary Syndrome 3Pituitary ACTH Hypersecretion 3Hyperprolactinemia 2Acromegaly 2Recurrence 1Prostatic Neoplasms 1Prolactin Deficiency, Isolated 1Ovarian Hyperstimulation Syndrome 1Neuroendocrine Tumors 1Neoplasms 1Melanoma 1Heart Valve Diseases 1Dumping Syndrome 1Breast Neoplasms 1Brain Neoplasms 1Adrenocortical Hyperfunction 1Adenoma 1ACTH-Secreting Pituitary Adenoma 1

Interventions

Dopamine Agonists 1Cabergoline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prolactin Deficiency, Isolated × Cabergoline × Clear all
NCT07045935 2025-09-23

ProBOLIC

University Hospital, Basel, Switzerland

Phase 4 Recruiting
60 enrolled

Prolactin Deficiency, Isolated, Hyperprolactinemia, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡